Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-07-20Clinical Trial Update: An Exploratory Study of Rebamipide in Patients With Active Ulcerative Colitis [Phase 2]
Phase 2 exploratory study of rebamipide in patients with active ulcerative colitis has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-07-19Clinical Trial Update: Golimumab Effect in the Modulation of Gut Microbiota in Ulcerative Colitis
Clinical trial investigating golimumab's effect on gut microbiota modulation in ulcerative colitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-07-01Clinical Trial Update: Study of the Golimumab Exposure-Response Relationship Using Serum Trough Levels [Phase 4]
Phase 4 clinical trial updating the exposure-response relationship of golimumab using serum trough levels in ulcerative colitis; results pos…
-
CLINICAL_TRIALS trial_result · 2021-06-23Clinical Trial Update: Safety and Tolerability of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis. [Phase 3]
Phase 3 trial update on SPD476 assessing safety and tolerability for maintaining remission in ulcerative colitis.
-
CLINICAL_TRIALS trial_result · 2021-06-23Clinical Trial Update: Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With Ulcerative Colitis (UC) [Phase 2]
Phase 2 trial investigating pharmacokinetics of adalimumab with methotrexate for ulcerative colitis; study terminated with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-06-15Clinical Trial Update: A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors [Phase 3]
Phase 3 trial assessing etrolizumab for maintenance of disease remission in tumor necrosis factor inhibitor-naive ulcerative colitis patient…
-
CLINICAL_TRIALS trial_result · 2021-06-15Clinical Trial Update: A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors [Phase 3]
Phase 3 trial assessing the efficacy and safety of etrolizumab in ulcerative colitis patients previously treated with TNF inhibitors has com…
-
CLINICAL_TRIALS trial_result · 2021-06-11Clinical Trial Update: BI655130 (SPESOLIMAB) Induction Treatment in Patients With Moderate-to-severe Ulcerative Colitis [Phase 2, Phase 3]
Phase 2/3 trial update for SPESOLIMAB (BI655130) as induction therapy in adults with moderate-to-severe ulcerative colitis; results have bee…
-
CLINICAL_TRIALS trial_result · 2021-06-11Clinical Trial Update: Safety and Efficacy of SPD476 (Mesalazine) Given Twice Daily (2.4 g/Day) vs SPD476 Given as a Single Dose (4.8 g/Day) in Subjects With Acute Mild to Moderate Ulcerative Colitis [Phase 3]
Phase 3 trial comparing twice-daily mesalazine to once-daily dosing in acute mild to moderate ulcerative colitis; completed study evaluating…
-
CLINICAL_TRIALS trial_result · 2021-06-11Clinical Trial Update: Efficacy and Safety of Two Doses of SPD476 (Mesalazine) 2.4g and 4.8g Once Daily, With Reference to Asacol 0.8g Three Times Daily in Subjects With Acute, Mild to Moderate Ulcerative Colitis [Phase 3]
Phase 3 trial update comparing two daily doses of SPD476 (mesalazine) with reference therapy in acute mild-to-moderate ulcerative colitis to…
-
CLINICAL_TRIALS trial_result · 2021-06-11Clinical Trial Update: Phase II Dose-Ranging Study in Subjects With Mild to Moderate Ulcerative Colitis Treated With SPD476 [Phase 2]
A Phase II dose-ranging study evaluating SPD476 in subjects with mild to moderate ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2021-06-09Clinical Trial Update: Efficacy and Safety of Vedolizumab in Biologic-naïve Korean Patients With Moderate to Severe Inflammatory Bowel Disease [Phase 3]
Phase 3 trial evaluating vedolizumab in biologic-naïve Korean patients with moderate to severe inflammatory bowel disease (Crohn's disease a…
-
CLINICAL_TRIALS trial_result · 2021-06-08Clinical Trial Update: A Trial of Yoga in Pediatric Inflammatory Bowel Disease [NA]
A completed clinical trial investigated yoga as an intervention for pediatric inflammatory bowel disease; results have been posted.
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: Berberine Chloride in Preventing Colorectal Cancer in Patients With Ulcerative Colitis in Remission [Phase 1]
Phase 1 trial assessing berberine chloride to prevent colorectal cancer in patients with ulcerative colitis in remission has completed with …
-
CLINICAL_TRIALS trial_result · 2021-05-18Clinical Trial Update: 5-HTP in Patients With IBD in Clinical and Biologic Remission:Effect on Fatigue Scores [Phase 2]
Phase 2 trial evaluating 5-HTP in patients with inflammatory bowel disease in clinical and biologic remission to assess effects on fatigue s…
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: Anthocyanin Rich Extract (ACRE) in Patients With Ulcerative Colitis [Phase 2]
Phase 2 clinical trial investigating Anthocyanin Rich Extract (ACRE) in patients with Ulcerative Colitis has been completed.
-
CLINICAL_TRIALS trial_result · 2021-05-07Clinical Trial Update: Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis [Phase 3]
Phase 3 trial of SHP647 as induction therapy in moderate to severe ulcerative colitis was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-30Clinical Trial Update: A Dose-finding Study of OPC-6535 in Patients With Active Ulcerative Colitis [Phase 2]
Phase 2 dose-finding study of OPC-6535 in active ulcerative colitis has been terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-28Clinical Trial Update: Fecal Microbiota Transplantation (FMT) in the Treatment of Pouchitis [Phase 2]
Phase 2 clinical trial update on fecal microbiota transplantation for pouchitis and ulcerative colitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-26Clinical Trial Update: Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis [Phase 3]
Phase 3 trial of SHP647 in moderate-to-severe ulcerative colitis was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-21Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis [Phase 3]
Phase 3 trial evaluating filgotinib for induction and maintenance of remission in adults with moderately to severely active ulcerative colit…
-
CLINICAL_TRIALS trial_result · 2021-04-15Clinical Trial Update: A Study of Tofacitinib in Patients With Ulcerative Colitis in Stable Remission [Phase 4]
Phase 4 clinical trial evaluating tofacitinib in ulcerative colitis patients in stable remission; study terminated with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2021-04-05Clinical Trial Update: A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors [Phase 3]
Phase 3 trial comparing etrolizumab to adalimumab and placebo in TNF inhibitor–naive moderate-to-severe ulcerative colitis completed with po…
-
CLINICAL_TRIALS trial_result · 2021-04-05Clinical Trial Update: Safety and Efficacy of Etrasimod (APD334) in Patients With Ulcerative Colitis [Phase 2]
Phase 2 clinical trial assessing safety and efficacy of etrasimod (APD334) in patients with ulcerative colitis has completed with results po…
-
CLINICAL_TRIALS trial_result · 2021-03-22Clinical Trial Update: Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis [Phase 2]
Phase 2 safety and efficacy study of PTG-100 for moderate to severe ulcerative colitis was terminated, and results have been posted.